Pages that link to "Q22242009"
Jump to navigation
Jump to search
The following pages link to BTS guidelines for the management of community acquired pneumonia in adults: update 2009 (Q22242009):
Displaying 50 items.
- pneumonia (Q12192) (← links)
- Antibiotics for community-acquired pneumonia in adult outpatients (Q24193127) (← links)
- Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults (Q24200609) (← links)
- Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients (Q24235438) (← links)
- Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998-2014 (Q24658576) (← links)
- Severe community-acquired pneumonia: timely management measures in the first 24 hours (Q26738591) (← links)
- Methodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectiveness (Q26770693) (← links)
- Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis (Q26774000) (← links)
- Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis (Q26777020) (← links)
- Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma (Q26777935) (← links)
- Viral-bacterial interactions-therapeutic implications (Q26825261) (← links)
- Duration of antimicrobial therapy in community acquired pneumonia: less is more (Q26828493) (← links)
- Community-acquired pneumonia: identification and evaluation of nonresponders (Q27002420) (← links)
- Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations (Q28066877) (← links)
- Lung ultrasound: a promising tool to monitor ventilator-associated pneumonia in critically ill patients (Q28074609) (← links)
- Surveillance of antibiotic resistance (Q28082571) (← links)
- Accuracy of Lung Ultrasonography versus Chest Radiography for the Diagnosis of Adult Community-Acquired Pneumonia: Review of the Literature and Meta-Analysis (Q28084889) (← links)
- Ceftobiprole medocaril in the treatment of hospital-acquired pneumonia (Q28085517) (← links)
- Viral pneumonia (Q28307886) (← links)
- Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals (Q28587900) (← links)
- Risk factors for hospital admission in the 28 days following a community-acquired pneumonia diagnosis in older adults, and their contribution to increasing hospitalisation rates over time: a cohort study (Q28604186) (← links)
- Postviral Complications: Bacterial Pneumonia (Q29248089) (← links)
- Healthcare-Associated Pneumonia Does Not Accurately Identify Potentially Resistant Pathogens: A Systematic Review and Meta-Analysis (Q29543747) (← links)
- Failure of CRP decline within three days of hospitalization is associated with poor prognosis of Community-acquired Pneumonia (Q30160730) (← links)
- Community-Acquired Pneumonia in HIV-Positive Patients: an Update on Etiologies, Epidemiology and Management. (Q30238577) (← links)
- Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults (Q30398779) (← links)
- Management of Legionella in the intensive care setting (Q30417993) (← links)
- Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units (Q30420451) (← links)
- Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study (Q30422390) (← links)
- Approaching the quality of antibiotic prescriptions in primary care using reimbursement data (Q30566077) (← links)
- The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UK Primary Care data (Q31100154) (← links)
- Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts (Q31108856) (← links)
- Influenza and pneumococcal vaccination in patients with rheumatoid arthritis in comparison with age- and sex-matched controls: results of a claims data analysis. (Q31111950) (← links)
- Do influenza and pneumococcal vaccines prevent community-acquired respiratory infections among older people with diabetes and does this vary by chronic kidney disease? A cohort study using electronic health records (Q33552701) (← links)
- Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study. (Q33581932) (← links)
- Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis (Q33586621) (← links)
- The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review (Q33701151) (← links)
- Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance (Q33749940) (← links)
- Oral versus intravenous clarithromycin in moderate to severe community-acquired pneumonia: an observational study (Q33801782) (← links)
- Defining and predicting severe community-acquired pneumonia. (Q33872274) (← links)
- Evaluation of Curetis Unyvero, a multiplex PCR-based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia (Q33900108) (← links)
- The management of community-acquired pneumonia in the elderly (Q33915736) (← links)
- Association between hospital case volume and mortality in non-elderly pneumonia patients stratified by severity: a retrospective cohort study. (Q33928093) (← links)
- Efficacy and safety of moxifloxacin in community acquired pneumonia: a prospective, multicenter, observational study (CAPRIVI). (Q33929402) (← links)
- Novel aspects on the pathogenesis of Mycoplasma pneumoniae pneumonia and therapeutic implications (Q34023899) (← links)
- Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review. (Q34096701) (← links)
- Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia (Q34419979) (← links)
- Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults (Q34462623) (← links)
- Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain). (Q34462908) (← links)
- Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. (Q34478074) (← links)